<SEC-DOCUMENT>0000950103-25-014164.txt : 20251103
<SEC-HEADER>0000950103-25-014164.hdr.sgml : 20251103
<ACCEPTANCE-DATETIME>20251103173116
ACCESSION NUMBER:		0000950103-25-014164
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251103
DATE AS OF CHANGE:		20251103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251445386

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251445387

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236836_424b2-us2514701d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 67%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Filed
    Pursuant to Rule 424(b)(2)</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Registration
    Statement Nos. 333-270327 and 333-270327-01</B></FONT></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 76%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>October 30, 2025</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>Medium-Term Senior
    Notes, Series N </B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>Pricing Supplement
    No. 2025-USNCH28629 to Product Supplement No. EA-09-02<BR>
    dated March 23, 2023, Underlying Supplement No. 11 dated March 7, 2023 and<BR>
    Prospectus Supplement and Prospectus each dated March 7, 2023</B></FONT></P></TD>
    <TD STYLE="white-space: nowrap; width: 24%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><IMG SRC="image_001.jpg" ALT="citi_logo_Blue" STYLE="height: 65px; width: 94px"></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; text-align: justify; color: #BB0826"><B>Citigroup Global
Markets Holdings Inc.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; text-align: justify; color: #BB0826"><B>All Payments
Due from Citigroup Global Markets Holdings Inc. Fully and Unconditionally Guaranteed by Citigroup Inc.</B></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside
Participation to a Cap and Principal Return at Maturity</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP>
Index due November 2, 2028&nbsp;&nbsp; </B></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.5pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Linked
to the EURO STOXX 50<SUP>&reg;</SUP> Index (the &ldquo;underlying&rdquo;) </FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Unlike
ordinary debt securities, the notes do not pay interest.&nbsp;Instead, the notes provide for a maturity payment amount that may be greater
than or equal to the stated principal amount of the notes, depending on the performance of the underlying from the starting value to
the ending value, subject to the maximum return. The maturity payment amount will reflect the following terms:</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 35.75pt; text-align: justify; text-indent: -13.95pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If
the ending value is greater than the starting value, you will receive the stated principal amount plus a positive return equal to 100%
of the percentage increase in the value of the underlying from the starting value, subject to a maximum return of 21.00% of the stated
principal amount</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 35.75pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If
the ending value is less than or equal to the starting value, you will be repaid the stated principal amount but will not receive any
positive return on your investment</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Repayment
of principal at maturity regardless of underlying performance (subject to issuer credit risk)</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;All
payments on the notes are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.; if Citigroup Global
Markets Holdings Inc. and Citigroup Inc. default on their obligations, you could lose some or all of your investment</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
periodic interest payments or dividends</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;The
notes will not be listed on any securities exchange and, accordingly, may have limited or no liquidity.&nbsp;&nbsp;You should not invest
in the notes unless you are willing to hold them to maturity.</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The notes have complex features and investing
in the notes involves risks not associated with an investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo;
beginning on page PS-6 and &ldquo;Risk Factors&rdquo; beginning on page PS-5 of the accompanying product supplement and beginning on
page S-1 of the accompanying prospectus supplement. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the notes or determined that this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The notes are unsecured debt obligations issued
by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc.&nbsp;&nbsp;All payments due on the notes are subject to the
credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.&nbsp;&nbsp;None of Wells Fargo Securities, LLC (&ldquo;Wells
Fargo&rdquo;) or any of its affiliates will have any liability to the purchasers of the notes in the event Citigroup Global Markets Holdings
Inc. defaults on its obligations under the notes and Citigroup Inc. defaults on its guarantee obligations.&nbsp;&nbsp;The notes are not
bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are
they obligations of, or guaranteed by, a bank.</B></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; width: 54%; border-bottom: white 1pt solid; border-right: white 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 22%; border-bottom: Black 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Per Note</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 24%; border-bottom: Black 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Total</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Public Offering Price<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$3,033,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Underwriting Discount and Commission<SUP>(2)(3)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$32.80</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$99,482.40</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Proceeds to Citigroup Global Markets Holdings Inc.<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$967.20</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$2,933,517.60</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(1) On the date of
this pricing supplement, the estimated value of the notes is $953.50 per note, which is less than the public offering price.&nbsp;&nbsp;The
estimated value of the notes is based on Citigroup Global Markets Inc.&rsquo;s (&ldquo;CGMI&rdquo;) proprietary pricing models and our
internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price,
if any, at which any person may be willing to buy the notes from you at any time after issuance.&nbsp;&nbsp;See &ldquo;Valuation of the
Notes&rdquo; in this pricing supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(2) CGMI, an affiliate
of Citigroup Global Markets Holdings Inc., as the lead agent for the offering, has agreed to sell the notes to Wells Fargo, as agent.
Wells Fargo will receive an underwriting discount and commission of 3.28% ($32.80) for each note it sells. Wells Fargo may pay selected
dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name of the retail brokerage business of its affiliates,
Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), a fixed selling commission of 2.25% ($22.50) for
each note they sell.&nbsp;&nbsp;In addition to the selling commission allowed to WFA, Wells Fargo may pay $0.75 per note of the underwriting
discount and commission to WFA as a distribution expense fee for each note sold by WFA. The total underwriting discount and commission
and proceeds to Citigroup Global Markets Holdings Inc. shown above give effect to the actual underwriting discount and commission provided
for the sale of the notes.&nbsp;&nbsp;See &ldquo;Supplemental Plan of Distribution&rdquo; below and &ldquo;Use of Proceeds and Hedging&rdquo;
in the accompanying prospectus for further information regarding how we have hedged our obligations under the notes.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt; background-color: white">(3)
In respect of certain notes sold in this offering, CGMI may pay a fee of up to $2.00 per note to selected securities dealers in consideration
for marketing and other services in connection with the distribution of the notes to other securities dealers.</FONT></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>Citigroup
    Global Markets Inc.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>Wells
    Fargo Securities</B></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; width: 100%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Terms
    of the Notes</B></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 20%; border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Underlying:</B></FONT></TD>
    <TD STYLE="width: 80%; padding-left: 5.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">The EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">All payments due on the notes are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Stated Principal Amount:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 per note. References in this pricing supplement to a &ldquo;note&rdquo; are to a note with a stated principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">October 30, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">November 4, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Calculation Day:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">October 30, 2028, subject to postponement if such date is not a trading day or certain market disruption events occur as described in the accompanying product supplement. </FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Maturity Date:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">November 2, 2028, subject to postponement as described in the accompanying product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Maturity Payment Amount:</B></FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-left: 5.3pt; margin-top: 0pt; margin-bottom: 0pt">For each $1,000 stated principal amount note you hold at maturity: &nbsp;</P>
                                    <P STYLE="margin-left: 5.3pt; margin-top: 0pt; margin-bottom: 0pt">&bull;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;If the ending value is greater than the starting value:</P>
                                    <P STYLE="margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;$1,000 plus the lesser of: &nbsp;</P>
                                    <P STYLE="margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;(i) $1,000 &times; underlying return &times; participation rate; and</P>
                                    <P STYLE="margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;(ii) the maximum return &nbsp;</P>
                                    <P STYLE="margin-left: 5.3pt; margin-top: 0pt; margin-bottom: 0pt">&bull;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;If the ending value is less than or equal to the starting value:&nbsp;&nbsp;$1,000 &nbsp;</P>
                                    <P STYLE="margin-left: 5.3pt; margin-top: 0pt; margin-bottom: 0pt"><B>If the ending value is less than or equal to the starting
                                    value, you will be repaid the stated principal amount of the notes at maturity but will not receive
                                    any positive return on your investment.</B></P></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Participation Rate:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">100% </FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Maximum Return:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">21.00% of the stated principal amount ($210 per note). Because of the maximum return, the maturity payment amount will not exceed $1,210 per note.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Starting Value:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">5,699.18, the closing value of the underlying on the pricing date</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Ending Value:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">The closing value of the underlying on the calculation day</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Underlying Return:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">(ending value &ndash; starting value) / starting value</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">CGMI</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">17333MV26 / US17333MV262 </FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Additional
    Information</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of the notes are set forth in the accompanying
product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying product
supplement, underlying supplement, prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing
supplement.&nbsp;&nbsp;For example, the accompanying product supplement contains important information about how the closing value of
the underlying will be determined and other specified events with respect to the underlying.&nbsp;&nbsp;The accompanying underlying supplement
contains information about the underlying that is not repeated in this pricing supplement.&nbsp;&nbsp;It is important that you read the
accompanying product supplement, underlying supplement, prospectus supplement and prospectus together with this pricing supplement in
connection with your investment in the notes.&nbsp;&nbsp;Certain terms used but not defined in this pricing supplement are defined in
the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When we refer to &ldquo;we,&rdquo; &ldquo;us&rdquo;
and &ldquo;our&rdquo; in this pricing supplement, we refer only to Citigroup Global Markets Holdings Inc. and not to any of its affiliates,
including Citigroup Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access the product supplement, underlying
supplement and prospectus supplement and prospectus on the SEC website www.sec.gov as follows (or if such address has changed, by reviewing
our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Product Supplement No. EA-09-02 dated March 23, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323004585/dp190174_424b2-wf0902.htm" STYLE="color: Blue; text-decoration: underline">https://www.sec.gov/Archives/edgar/data/200245/000095010323004585/dp190174_424b2-wf0902.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Underlying Supplement No. 11 dated March 7, 2023:<FONT STYLE="background-color: yellow"><BR>
</FONT></FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-size: 10pt">https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Prospectus Supplement and Prospectus, each dated March 7, 2023:<FONT STYLE="background-color: yellow"><BR>
</FONT></FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-size: 10pt">https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Investor
    Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The notes are not appropriate for all investors.
The notes may be an appropriate investment for investors who: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek exposure to any upside performance of the underlying without exposure to any decline in the underlying,
by:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">participating at the specified participation rate in the percentage increase, if any, from the starting
value to the ending value, subject to the maximum return; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">providing for the repayment of the stated principal amount at maturity regardless of the performance of
the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">understand that if the ending value is less than or equal to the starting value, they will not receive
any positive return on their investment in the notes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are willing to forgo interest payments on the notes and dividends on securities included in the underlying;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are willing to hold the notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The notes may not be an appropriate investment
for investors who: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek a liquid investment or are unable or unwilling to hold the notes to maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek certainty of receiving a positive return on their investment;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek uncapped exposure to the upside performance of the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek current income;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to purchase notes with the estimated value set forth on the cover page;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to accept the risk of exposure to the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek exposure to the underlying but are unwilling to accept the risk/return trade-offs inherent in the
maturity payment amount for the notes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to accept the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">prefer the lower risk of fixed income investments with comparable maturities issued by companies with
comparable credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify"><B>The considerations identified above
are not exhaustive. Whether or not the notes are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an investment in the notes in light of your particular circumstances. You should also review carefully the &ldquo;Summary
Risk Factors&rdquo; herein and the &ldquo;Risk Factors&rdquo; in the accompanying product supplement for risks related to an investment
in the notes. For more information about the underlying, please see the information provided below. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Determining
    Maturity Payment Amount</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On
the maturity date, you will receive a cash payment per note (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Summary
    Risk Factors</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the notes is significantly riskier
than an investment in conventional debt securities.&nbsp;&nbsp;The notes are subject to all of the risks associated with an investment
in our conventional debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations
under the notes, and are also subject to risks associated with the underlying.&nbsp;&nbsp;Accordingly, the notes are appropriate only
for investors who are capable of understanding the complexities and risks of the notes.&nbsp;&nbsp;You should consult your own financial,
tax and legal advisors as to the risks of an investment in the notes and the appropriateness of the notes in light of your particular
circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of certain key risk
factors for investors in the notes.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks relating
to an investment in the notes contained in the section &ldquo;Risk Factors&rdquo; beginning on page PS-5 in the accompanying product supplement.&nbsp;&nbsp;You
should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated by reference
in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports
on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>You May Not Receive Any Positive
Return On Your Investment In The Notes.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">You will receive a positive
return on your investment in the notes only if the ending value is greater than the starting value. If the ending value is equal to or
less than the starting value, you will receive only the stated principal amount for each note you hold at maturity. As the notes do not
pay any interest, even if the ending value is greater than the starting value, there is no assurance that your total return at maturity
on the notes will be as great as could have been achieved on conventional debt securities of ours or of another issuer with a similar
credit rating of comparable maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>The Notes Do Not Pay Interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Unlike conventional debt securities,
the notes do not pay interest or any other amounts prior to maturity. You should not invest in the notes if you seek current income during
the term of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Your Potential Return On
The Notes Is Limited.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Your potential total return
on the notes at maturity is limited to the maximum return. Your return on the notes will not exceed the maximum return, even if the underlying
appreciates by significantly more than the maximum return. If the underlying appreciates by more than the maximum return, the notes will
underperform an alternative investment providing 1-to-1 exposure to the performance of the underlying.&nbsp;&nbsp;When lost dividends
are taken into account, the notes may underperform an alternative investment providing 1-to-1 exposure to the performance of the underlying
and a pass-through of dividends even if the underlying appreciates by less than the maximum return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>You Will Not Receive Dividends
Or Have Any Other Rights With Respect To The Securities Included In The Underlying.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">You will not receive any dividends
with respect to the securities included in the underlying.&nbsp;&nbsp;This lost dividend yield may be significant over the term of the
notes.&nbsp;&nbsp;The payment scenarios described in this pricing supplement do not show any effect of lost dividend yield over the term
of the notes.&nbsp;&nbsp;In addition, you will not have voting rights or any other rights with respect to the securities included in the
underlying.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Your Maturity Payment Amount
Depends On The Value Of The Underlying On A Single Day.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Because your maturity payment
amount depends on the value of the underlying solely on the calculation day, you are subject to the risk that the value of the underlying
on that day may be lower, and possibly significantly lower, than on one or more other dates during the term of the notes. If you had invested
in another instrument linked to the underlying that you could sell for full value at a time selected by you, or if the maturity payment
amount were based on an average of values of the underlying, you might have achieved better returns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Although The Notes Provide
For The Repayment Of The Stated Principal Amount At Maturity, You May Nevertheless Suffer A Loss On Your Investment In Real Value Terms
If The Percentage Change From The Starting Value to the Ending Value Is Less Than Or Not Sufficiently Greater Than Zero. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This is because inflation may
cause the real value of the stated principal amount to be less at maturity than it is at the time you invest, and because an investment
in the notes represents a forgone opportunity to invest in an alternative asset that does generate a positive real return. This potential
loss in real value terms is significant given the term of the notes. You should carefully consider whether an</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">investment that may not provide
for any positive return on your investment, or may provide a return that is lower than the return on alternative investments, is appropriate
for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>The Notes Are Subject To
The Credit Risk Of Citigroup Global Markets Holdings Inc. And Citigroup Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">If we default on our obligations
under the notes and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you under the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Notes Will Not Be Listed On Any Securities
Exchange And You May Not Be Able To Sell Them Prior To Maturity. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The notes will not be listed on any securities
exchange. Therefore, there may be little or no secondary market for the notes. We have been advised that Wells Fargo currently intends
to make a secondary market in relation to the notes. However, Wells Fargo may suspend or terminate making a market without notice, at
any time and for any reason. If Wells Fargo suspends or terminates making a market, there may be no secondary market at all for the notes
because it is likely that Wells Fargo will be the only broker-dealer that is willing to buy your notes prior to maturity. Accordingly,
an investor must be prepared to hold the notes until maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Sale Of The Notes Prior To Maturity May Result
In A Loss Of Principal.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will be entitled to receive at least the full
stated principal amount of your notes, subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc., only if
you hold the notes to maturity. The value of the notes may fluctuate during the term of the notes, and if you are able to sell your notes
prior to maturity, you may receive less than the full stated principal amount of your notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes On The Pricing
Date, Based On CGMI&rsquo;s Proprietary Pricing Models And Our Internal Funding Rate, Is Less Than The Public Offering Price. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The difference is attributable to certain costs
associated with selling, structuring and hedging the notes that are included in the public offering price. These costs include (i) any
selling concessions or other fees paid in connection with the offering of the notes, (ii) hedging and other costs incurred by us and our
affiliates in connection with the offering of the notes and (iii) the expected profit (which may be more or less than actual profit) to
CGMI or other of our affiliates and/or Wells Fargo or its affiliates in connection with hedging our obligations under the notes. These
costs adversely affect the economic terms of the notes because, if they were lower, the economic terms of the notes would be more favorable
to you. The economic terms of the notes are also likely to be adversely affected by the use of our internal funding rate, rather than
our secondary market rate, to price the notes. See &ldquo;The Estimated Value Of The Notes Would Be Lower If It Were Calculated Based
On Wells Fargo&rsquo;s Determination Of The Secondary Market Rate With Respect To Us&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes Was Determined
For Us By Our Affiliate Using Proprietary Pricing Models. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CGMI derived the estimated value disclosed on
the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have made discretionary judgments about
the inputs to its models, such as the volatility of the underlying, the dividend yields on the securities included in the underlying and
interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views, and as an underwriter in this offering,
CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models may prove to be wrong and therefore not an
accurate reflection of the value of the notes. Moreover, the estimated value of the notes set forth on the cover page of this pricing
supplement may differ from the value that we or our affiliates may determine for the notes for other purposes, including for accounting
purposes. You should not invest in the notes because of the estimated value of the notes. Instead, you should be willing to hold the notes
to maturity irrespective of the initial estimated value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes Would Be Lower
If It Were Calculated Based On Wells Fargo&rsquo;s Determination Of The Secondary Market Rate With Respect To Us. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated value of the notes included in this
pricing supplement is calculated based on our internal funding rate, which is the rate at which we are willing to borrow funds through
the issuance of the notes. We expect that our internal funding rate is generally lower than Wells Fargo&rsquo;s determination of the secondary
market rate with respect to us, which is the rate that we expect Wells Fargo will use in determining the value of the notes for purposes
of any purchases of the notes from you in the secondary market. If the estimated value included in this pricing supplement were based
on Wells Fargo&rsquo;s determination of the secondary market rate with respect to us, rather than our internal funding rate, it would
likely be lower. We determine our internal funding rate based on factors such as the costs associated with the notes, which are generally
higher than the costs associated with conventional debt securities, and our liquidity needs and preferences. Our internal funding rate
is not an interest rate that is payable on the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because there is not an active market for traded
instruments referencing our outstanding debt obligations, Wells Fargo may determine the secondary market rate with respect to us for purposes
of any purchase of the notes from you in the secondary market based on the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">market price of traded instruments referencing
the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the notes, but subject to adjustments
that Wells Fargo may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes Is Not An
Indication Of The Price, If Any, At Which Any Person May Be Willing To Buy The Notes From You In The Secondary Market. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such secondary market price will fluctuate
over the term of the notes based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value
included in this pricing supplement, we expect that any value of the notes determined for purposes of a secondary market transaction will
be based on Wells Fargo&rsquo;s determination of the secondary market rate with respect to us, which will likely result in a lower value
for the notes than if our internal funding rate were used. In addition, we expect that any secondary market price for the notes will be
reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the notes to be purchased in the secondary
market transaction, and may be reduced by the expected cost of unwinding related hedging transactions. As a result, it is likely that
any secondary market price for the notes will be less than the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Value Of The Notes Prior To Maturity Will
Fluctuate Based On Many Unpredictable Factors. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of your notes prior to maturity will
fluctuate based on the closing value of the underlying, the volatility of the closing value of the underlying, the dividend yields on
the securities included in the underlying, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s
creditworthiness, as reflected in our secondary market rate, among other factors described under <FONT STYLE="background-color: white">&ldquo;Ris</FONT>k
Factors&mdash;General Risk Factors Relating To All Notes&mdash; The Value Of Your Notes Prior To Maturity Will Fluctuate Based On Many
Unpredictable Factors&rdquo; in the accompanying product supplement.&nbsp;&nbsp;Changes in the value of the underlying may not result
in a comparable change in the value of your notes. You should understand that the value of your notes at any time prior to maturity may
be significantly less than the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We Have Been Advised That, Immediately Following
Issuance, Any Secondary Market Bid Price Provided By Wells Fargo, And The Value That Will Be Indicated On Any Brokerage Account Statements
Prepared By Wells Fargo Or Its Affiliates, Will Reflect A Temporary Upward Adjustment. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of this temporary upward adjustment
will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Notes&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The EURO STOXX 50<SUP>&reg;</SUP> Index Is
Subject To Risks Associated With Non-U.S. Markets.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The stocks included in the EURO STOXX 50<SUP>&reg;</SUP>
Index have been issued by companies outside of the U.S. Foreign equity securities involve risks associated with the securities markets
in foreign countries, including risks of volatility in those markets, governmental intervention in those markets and cross-shareholdings
in companies in certain countries. There is also generally less publicly available information about foreign companies than about U.S.
companies that are subject to the reporting requirements of the Securities and Exchange Commission, and foreign companies are subject
to accounting, auditing and financial reporting standards and requirements different from those applicable to U.S. reporting companies.
The prices of securities in foreign markets may be affected by political, economic, financial and social factors in those countries, or
global regions, including changes in government, economic and fiscal policies and currency exchange laws. Moreover, the economies in such
countries may differ unfavorably from the economy of the United States in such respects as growth of gross national product, rate of inflation,
capital reinvestment, resources and self-sufficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Performance Of The EURO STOXX 50<SUP>&reg;</SUP>
Index Will Not Be Adjusted For Changes In The Exchange Rate Between The Euro And The U.S. Dollar.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The EURO STOXX 50<SUP>&reg;</SUP> Index is composed
of stocks traded in euro, the value of which may be subject to a high degree of fluctuation relative to the U.S. dollar. However, the
performance of the EURO STOXX 50<SUP>&reg;</SUP> Index and the value of your notes will not be adjusted for exchange rate fluctuations.
If the euro appreciates relative to the U.S. dollar over the term of the notes, the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index
as measured for purposes of the notes will be less than it would have been if it offered exposure to that appreciation in addition to
the change in the prices of the underlying stocks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Offering Of The Notes Is Not A Recommendation
Of The Underlying. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fact that we are offering the notes does not
mean that we or Wells Fargo or its affiliates believe that investing in an instrument linked to the underlying is likely to achieve favorable
returns. In fact, as we and Wells Fargo and its affiliates are each part of respective global financial institutions, our affiliates and
affiliates of Wells Fargo may have positions (including short positions) in the underlying or in instruments related to the underlying,
and may publish research or express opinions, that in each case are inconsistent with an investment linked to the underlying. These and
other activities of our affiliates or of Wells Fargo or its affiliates may affect the closing value of the underlying in a way that negatively
affects the value of and your return on the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Closing Value Of The Underlying May Be
Adversely Affected By Our Or Our Affiliates&rsquo;, Or By Wells Fargo And Its Affiliates&rsquo;, Hedging And Other Trading Activities.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have hedged our obligations under the notes
through CGMI or other of our affiliates and/or Wells Fargo or its affiliates, who have taken positions in the underlying or in financial
instruments related to the underlying and may adjust such positions during the term of the notes. Our affiliates and Wells Fargo and its
affiliates may also take positions in the underlying or in financial instruments related to the underlying on a regular basis (taking
long or short positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf
of customers. These activities could affect the closing value of the underlying in a way that negatively affects the value of and your
return on the notes. They could also result in substantial returns for us or our affiliates or Wells Fargo and its affiliates while the
value of the notes declines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We And Our Affiliates And Wells Fargo And Its
Affiliates May Have Economic Interests That Are Adverse To Yours As A Result Of Our And Their Respective Business Activities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our affiliates and Wells Fargo and its affiliates
engage in business activities with a wide range of companies.&nbsp;&nbsp;These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services.&nbsp;&nbsp;These activities could involve or affect the
underlying in a way that negatively affects the value of and your return on the notes. They could also result in substantial returns for
us or our affiliates or Wells Fargo or its affiliates while the value of the notes declines.&nbsp;&nbsp;In addition, in the course of
this business, we or our affiliates or Wells Fargo or its affiliates may acquire non-public information, which will not be disclosed to
you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Calculation Agent, Which Is An Affiliate
Of Ours, Will Make Important Determinations With Respect To The Notes. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If certain events occur during the term of the
notes, such as market disruption events and other events with respect to the underlying, CGMI, as calculation agent, will be required
to make discretionary judgments that could significantly affect your return on the notes.&nbsp;&nbsp;In making these judgments, the calculation
agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder of the notes.&nbsp;&nbsp;<FONT STYLE="background-color: white">See
&ldquo;Risk Facto</FONT>rs&mdash;General Risk Factors Relating To All Notes&mdash;The Calculation Agent, Which Is An Affiliate Of Ours,
Will Make Important Determinations With Respect To The Notes&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Changes That Affect The Underlying May Affect
The Value Of Your Notes. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sponsor of the underlying may at any time
make methodological changes or other changes in the manner in which it operates that could affect the value of the underlying.&nbsp;&nbsp;We
are not affiliated with the underlying sponsor and, accordingly, we have no control over any changes the sponsor may make.&nbsp;&nbsp;Such
changes could adversely affect the performance of the underlying and the value of and your return on the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Stated Maturity Date May Be Postponed If
The Calculation Day Is Postponed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The calculation day will be postponed for non-trading
days and certain market disruption events. If such a postponement occurs, the maturity date will be postponed. For more information regarding
adjustments to the calculation days and payment dates and the circumstances that may result in a market disruption event, see the relevant
sections of the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You Will Be Required To Recognize Taxable Income
On The Notes Prior To Maturity</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a U.S. holder of a note, you will be
required to recognize taxable interest income in each year that you hold the note, even though you will not receive any payment in respect
of the note prior to maturity (or earlier sale, exchange or retirement). In addition, any gain you recognize will be treated as ordinary
interest income rather than capital gain. You should review the section of this pricing supplement entitled &ldquo;United States Federal
Tax Considerations.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Hypothetical
    Examples and Returns</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate how to determine the maturity payment amount on the notes, assuming the various hypothetical ending values indicated
below.&nbsp;&nbsp;The examples are solely for illustrative purposes, do not show all possible outcomes and are not a prediction of what
the actual maturity payment amount on the notes will be.&nbsp;&nbsp;The actual maturity payment amount will depend on the actual ending
value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The examples below are based on a hypothetical
starting value of 100, rather than the actual starting value.&nbsp;&nbsp;For the actual starting value, see &ldquo;Terms of the Notes&rdquo;
above.&nbsp;&nbsp;We have used this hypothetical value, rather than the actual value, to simplify the calculations and aid understanding
of how the notes work.&nbsp;&nbsp;However, you should understand that the actual maturity payment amount on the notes will be calculated
based on the actual starting value, and not the hypothetical value indicated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_002.gif" ALT="" STYLE="width: 720px; height: 483px"></P>

<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Wingdings; color: #4A7EBB">n</FONT>&nbsp;The
Notes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<FONT STYLE="font-family: Wingdings">n</FONT>&nbsp;The Underlying&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: #688FCF 1pt solid; width: 25%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hypothetical</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ending value</B></P></TD>
    <TD STYLE="border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Hypothetical underlying return</B></FONT></TD>
    <TD STYLE="border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Hypothetical maturity payment amount per&nbsp;note</B></FONT></TD>
    <TD STYLE="border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Hypothetical total pre-tax rate&nbsp;of&nbsp;return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">200.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">175.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">150.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">140.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">130.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">121.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,200.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,100.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">10.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,050.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">5.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-20.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-30.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">25.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Examples</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1&mdash;Upside Scenario A.</B> The
hypothetical ending value is 105 (a 5% increase from the starting value), which is <B>greater than</B> the starting value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity payment amount per note = $1,000 <I>plus </I>the lesser of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i) $1,000 &times; underlying return &times; participation rate and
(ii) the maximum return</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) ($1,000 &times; 5% &times; 100%) and
(ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) $50 and (ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,050</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the underlying appreciated from the starting
value to the hypothetical ending value, you would receive a total return at maturity equal to the upside performance of the underlying
<I>multiplied by</I> the participation rate, which in this case is less than the maximum return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2&mdash;Upside Scenario B.</B> The
hypothetical ending value is 175 (a 75% increase from the starting value), which is <B>greater than</B> the starting value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity payment amount per note = $1,000 <I>plus </I>the lesser of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i) $1,000 &times; underlying return &times; participation rate and
(ii) the maximum return</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) ($1,000 &times; 75% &times; 100%) and
(ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) $750 and (ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the underlying appreciated from the starting
value to the hypothetical ending value and the upside performance of the underlying <I>multiplied by</I> the participation rate exceeds
the maximum return, your total return at maturity would be limited to the maximum return in this case. In this scenario, an investment
in the notes would underperform a hypothetical alternative investment providing 1-to-1 exposure to the appreciation of the underlying
without a maximum return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3&mdash;Par Scenario.</B> The hypothetical
ending value is 90 (a 10% decrease from the starting value), which is <B>less than</B> the starting value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity payment amount per note = $1,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending value is less
than the starting value, you would be repaid the stated principal amount of your notes at maturity but would not receive any positive
return on your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Information
    About the EURO STOXX 50<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The EURO STOXX 50<SUP>&reg;</SUP> Index is composed
of 50 component stocks of market sector leaders from within the EURO STOXX<SUP>&reg;</SUP> Supersector indices, which represent the Eurozone
portion of the STOXX Europe 600<SUP>&reg;</SUP> Supersector indices. The STOXX Europe 600<SUP>&reg;</SUP> Supersector indices contain
the 600 largest stocks traded on the major exchanges of certain European countries. The EURO STOXX 50<SUP>&reg;</SUP> Index is calculated
and maintained by STOXX Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please refer to the section &ldquo;Equity Index
Descriptions&mdash; The STOXX Benchmark Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have derived all information regarding the
EURO STOXX 50<SUP>&reg;</SUP> Index from publicly available information and have not independently verified any information regarding
the EURO STOXX 50<SUP>&reg;</SUP> Index. This pricing supplement relates only to the notes and not to the EURO STOXX 50<SUP>&reg;</SUP>
Index. We make no representation as to the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index over the term of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The notes represent obligations of Citigroup Global
Markets Holdings Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the EURO STOXX 50<SUP>&reg;</SUP> Index is not involved in any
way in this offering and has no obligation relating to the notes or to holders of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Historical Information </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The closing value of the EURO STOXX 50<SUP>&reg;</SUP> Index on October
30, 2025 was 5,699.18.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The graph below shows the closing value of the
EURO STOXX 50<SUP>&reg;</SUP> Index for each day such value was available from January 2, 2020 to October 30, 2025.&nbsp;&nbsp;We obtained
the closing values from Bloomberg L.P., without independent verification.&nbsp;&nbsp;You should not take historical closing values as
an indication of future performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_003.gif" ALT="" STYLE="height: 398px; width: 720px"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>United
    States Federal Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of our counsel, Davis Polk &amp;
Wardwell LLP, which is based on current market conditions, the notes should be treated as &ldquo;contingent payment debt instruments&rdquo;
for U.S. federal income tax purposes, as described in the section of the accompanying product supplement called &ldquo;United States Federal
Tax Considerations&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Contingent Payment Debt Instruments,&rdquo; and the remaining
discussion is based on this treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a U.S. Holder (as defined in the accompanying
product supplement), you will be required to recognize interest income during the term of the notes at the &ldquo;comparable yield,&rdquo;
which generally is the yield at which we could issue a fixed-rate debt instrument with terms similar to those of the notes, including
the level of subordination, term, timing of payments and general market conditions, but excluding any adjustments for the riskiness of
the contingencies or the liquidity of the notes. We are required to construct a &ldquo;projected payment schedule&rdquo; in respect of
the notes representing a payment the amount and timing of which would produce a yield to maturity on the notes equal to the comparable
yield. Assuming you hold the notes until their maturity, the amount of interest you include in income based on the comparable yield in
the taxable year in which the notes mature will be adjusted upward or downward to reflect the difference, if any, between the actual and
projected payment on the notes at maturity as determined under the projected payment schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the sale, exchange or retirement of the notes
prior to maturity, you generally will recognize gain or loss equal to the difference between the proceeds received and your adjusted tax
basis in the notes. Your adjusted tax basis will equal your purchase price for the notes, increased by interest previously included in
income on the notes. Any gain generally will be treated as ordinary income, and any loss generally will be treated as ordinary loss to
the extent of prior interest inclusions on the note and as capital loss thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have determined that the comparable yield for
a note is a rate of 3.971%, compounded semi-annually, and that the projected payment schedule with respect to a note consists of a single
payment of $1,125.051 at maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>ACCRUAL PERIOD</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>OID DEEMED TO ACCRUE DURING ACCRUAL PERIOD (PER NOTE)</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>TOTAL OID DEEMED TO HAVE ACCRUED FROM ISSUE DATE (PER NOTE) AS OF END OF ACCRUAL PERIOD</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">Issue Date</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 6%; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2025</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 27%; text-align: center"><FONT STYLE="font-size: 10pt">$6.177</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt">$16.177</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">January 1, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">June 30, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$19.978</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$26.155</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$20.374</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$46.529</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">January 1, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">June 30, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$20.779</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$67.308</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$21.191</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$88.499</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">January 1, 2028</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">June 30, 2028</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$21.612</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$110.111</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2028</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">Maturity Date</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$14.939</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$125.051</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the comparable yield nor the projected
payment schedule constitutes a representation by us regarding the actual amount that we will pay on the notes. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-U.S. Holders.</B> Subject to the discussions
below regarding Section 871(m) and in &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo;
and &ldquo;&mdash;FATCA&rdquo; in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying product
supplement) of the notes, under current law you generally will not be subject to U.S. federal withholding or income tax in respect of
any payment on or any amount received on the sale, exchange or retirement of the notes, provided that (i) income in respect of the notes
is not effectively connected with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification
requirements. See &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo; in the accompanying
product supplement for a more detailed discussion of the rules applicable to Non-U.S. Holders of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed under &ldquo;United States Federal
Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&mdash;Dividend Equivalents Under Section 871(m) of the Code&rdquo; in the
accompanying product supplement, Section 871(m) of the Internal Revenue Code of 1986, as amended, and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;Underlying Securities&rdquo;) or indices that include
Underlying Securities. Section 871(m) generally applies to instruments that substantially replicate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the economic performance of one or more Underlying
Securities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations, as modified by an
Internal Revenue Service (&ldquo;IRS&rdquo;) notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo;
of one. Based on the terms of the notes and representations provided by us, our counsel is of the opinion that the notes should not be
treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any Underlying Security
and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A determination that the notes are not subject
to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its
application may depend on your particular circumstances, including your other transactions. You should consult your tax adviser regarding
the potential application of Section 871(m) to the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If withholding tax applies to the notes, we will
not be required to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should read the section entitled &ldquo;United
States Federal Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with
that section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the notes. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should also consult your tax adviser regarding
all aspects of the U.S. federal tax consequences of an investment in the notes and any tax consequences arising under the laws of any
state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #0070C0; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Supplemental
    Plan of Distribution</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the Amended and Restated
Global Selling Agency Agreement, dated April 7, 2017, CGMI, acting as principal, will purchase the notes from Citigroup Global Markets
Holdings Inc. CGMI, as the lead agent for the offering, has agreed to sell the notes to Wells Fargo, as agent.&nbsp;&nbsp;Wells Fargo
will receive an underwriting discount and commission of 3.28% ($32.80) for each note it sells.&nbsp;&nbsp;Wells Fargo may pay selected
dealers, which may include WFA, a fixed selling commission of 2.25% ($22.50) for each note they sell. In addition to the selling commission
allowed to WFA, Wells Fargo may pay $0.75 per note of the underwriting discount and commission to WFA as a distribution expense fee for
each note sold by WFA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">In addition,
in respect of certain notes sold in this offering, CGMI may pay a fee of up to $2.00 per note to selected securities dealers in consideration
for marketing and other services in connection with the distribution of the notes to other securities dealers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Valuation
    of the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CGMI calculated the estimated value of the notes
set forth on the cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated
an estimated value for the notes by estimating the value of a hypothetical package of financial instruments that would replicate the payout
on the notes, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the notes (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component using
a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The Value Of The Notes Prior To Maturity Will Fluctuate
Based On Many Unpredictable Factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have been advised that, for a period of approximately
three months following issuance of the notes, the price, if any, at which Wells Fargo would be willing to buy the notes from investors,
and the value that will be indicated for the notes on any brokerage account statements prepared by Wells Fargo or its affiliates, will
reflect a temporary upward adjustment from the price or value that would otherwise be determined.&nbsp;&nbsp;This temporary upward adjustment
represents a portion of the costs associated with selling, structuring and hedging the notes that are included in the public offering
price of the notes.&nbsp;&nbsp;The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period.&nbsp;&nbsp;However, Wells Fargo is not obligated to buy the notes from investors at any time.&nbsp;&nbsp;See
&ldquo;Summary Risk Factors&mdash;The Notes Will Not Be Listed On Any Securities Exchange And You May Not Be Able To Sell Them Prior To
Maturity.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Validity
    of the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special products counsel to Citigroup Global Markets Holdings Inc., when the notes offered by this pricing supplement have been executed
and issued by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against
payment therefor, such notes and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets
Holdings Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy,
insolvency and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general
applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel
expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions
expressed above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York,
except that such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In giving this opinion, Davis Polk &amp; Wardwell
LLP has assumed the legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup
Global Markets Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In
addition, this opinion is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024,
which has been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has
been duly authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the
terms of the notes nor the issuance and delivery of the notes and the related guarantee, nor the compliance by Citigroup Global Markets
Holdings Inc. and Citigroup Inc. with the terms of the notes and the related guarantee respectively, will result in a violation of any
provision of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable, or
any restriction imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup
Inc., as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the EURO STOXX 50<SUP>&reg;</SUP> Index due November 2, 2028</B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Alexia Breuvart, Secretary and
General Counsel of Citigroup Global Markets Holdings Inc., (i) the terms of the notes offered by this pricing supplement have been duly
established under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings
Inc. has duly authorized the issuance and sale of such notes and such authorization has not been modified or rescinded; (ii) Citigroup
Global Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has
been duly authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture
and of the notes offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global
Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation
or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws
of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alexia Breuvart, or other internal attorneys with
whom she has consulted, has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction,
of such corporate records of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis
for the opinions expressed above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the
genuineness of all signatures (other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents
submitted to her or such persons as originals, the conformity to original documents of all documents submitted to her or such persons
as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Karen Wang, Senior Vice President
&ndash; Corporate Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of
Citigroup Inc. has duly authorized the guarantee of such notes by Citigroup Inc. and such authorization has not been modified or rescinded;
(ii) Citigroup Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup
Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or
other constitutive documents.&nbsp;&nbsp;This opinion is given as of the date of this pricing supplement and is limited to the General
Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Karen Wang, or other internal attorneys with
whom she has consulted, has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction,
of such corporate records of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the
conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies and the authenticity
of the originals of such copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&copy; 2025 Citigroup Global Markets Inc. All
rights reserved. Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered
throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236836_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-03</xbrli:startDate>
          <xbrli:endDate>2025-11-03</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-03</xbrli:startDate>
          <xbrli:endDate>2025-11-03</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-03</xbrli:startDate>
          <xbrli:endDate>2025-11-03</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">3,033</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">3,033,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">418.86</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">3,033,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">418.86</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">418.86</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">3,033,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !! %X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "BL^]U[3-..V[OH(F'\)?G\JKQ>+=#G<)'J=ON/0%L?SJ>>*TN;+
M#U9+F4';T9L44V.1)4#QNKH>C*<@TZJ,0HHHH **** "BJ>J:K9Z+827FH3I
M! G5F[GT [FO/+WXV6<<Q6STJ:6,'AY) F?PP:N-.4]D%STR6:.")Y9G5(T!
M9F8X %>;:MXLU/Q-?G3O#ZR)"3C*<,X]2?X16UX:^(>C>+7^P30FWN9!Q;SX
M99/8'H?I4%EXXTR'QH_A^UT<03&<P&>,*H.!G. ,UG4H5)/EV[G9A,32H7G*
M'-+I?9%:T^&]O;V[7.MZCM"C=)L(55^K&HM,\)^&_$D%RVB7]V5MY/*:5L,I
M; /&0,CFF?$SQO!:PZAX<:TD:6:%<3!QM&>>GX5RG@/Q_;^$-.N+2:REN&GG
M\P,C@ ?*!CGZ5<<%%PO;4N6;8MRYN<Z&XL-?\"3BXMYO-L\\E<F,^S+V^M=O
MHGBNRUC29+P'RW@7,\74J?;U![5!XN\66WAO1H+NZLFNHKE@GE@CN,\YZU8\
M,SZ=KF@PZC:Z=%:QW:$,@10<9(P2![5E"C*'O+X2L1C88FG^\C[ZZKKZHDT+
MQ%!KAG6.&2)X3@A\'/XCN.XK8JEIVD6>E!_L<(0O@,<Y) Z#\*NUH[7T/."B
MBBD!XM\5K^YU?QC;:+"Q\N$(J)V,C]S^&*]#T3P!H6CV"0&QAN9MH\R:9 S.
M>_7H/:O.?BA;7&B^/+?5XT^241RQMV+IU'Z"O5-#\4Z7K^GI=6EU%RN7C9P&
MC/<$5TU+JG'EV$MS/LOA[H>G^(UU>UM_+=%^2$?ZM'_O =C7F]I_R7%_^O\
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KLDGID^M:U%)S;7* 4445(!1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $# T # 2(  A$! Q$!_\0
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M_A'K;_G_ -<_\'EY_P#':/\ A'K;_G_US_P>7G_QVM:BCFEW R?^$>MO^?\
MUS_P>7G_ ,=H_P"$>MO^?_7/_!Y>?_':UJ*.:7<#)_X1ZV_Y_P#7/_!Y>?\
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M>?\ QVC_ (1ZV_Y_]<_\'EY_\=K6HHYI=P,G_A'K;_G_ -<_\'EY_P#':/\
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M%.LC9S(ZJJC<1ALGG@<9Z?Q+9SZAX5UBRM4\RXN+&:*),@;F9" ,G@<GO19
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M:W4$@FVD5G &<JI7+ CH5!SVS7.V?C^TN8=%EELKF)=3@FE"K%+(ZM&8_E5
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MJ)66$A7,C@.I*'.XM@KP""&KO]'2_CT:S359$DOQ"HN'3&&?')X 'Y 4-);
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M+R5>-MR@Y502I8#YS][I71>'_P"UH--MX=56>:=GD/FR-$6CCW?NQ(5P"^W
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MCN;DV,ME \-KY2QK(!O<KO;<QVKW ^7@"MFSM)K*ULK9)HVBMX1%)F,[GPH
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M ($VG_Q^O7:*/:2#V43R+^RO$W_0IZC_ .!-I_\ 'Z/[*\3?]"GJ/_@3:?\
MQ^O7:*/:2#V43R$Z7XC4;I/"^H1H.6<W%J0H[GB8G\J1+35;G)T[1[J_5?OM
M#+"FP]@?,D7],UZQ??\ (/N?^N3?R-<SX%_X]KS_ 'U_D:I3?*V0X+F2./\
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MVJQKEHL_+,O_ #TB/\2G\QT.#6C7&TUHRB.""&U@C@MXDBAC4*D<:A551T
MX H@MX;9"D$,<2%F<K&H4%F)+'CN222>Y-244@"BBB@ HHHH **** "BBB@
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MYP_VS6_^A/UC_O\ V?\ \D4?;-;_ .A/UC_O_9__ "17<44>RB%SA_MFM_\
M0GZQ_P!_[/\ ^2*/MFM_]"?K'_?^S_\ DBNXHH]E$+G#_;-;_P"A/UC_ +_V
M?_R11]LUO_H3]8_[_P!G_P#)%=Q11[*(7.'^V:W_ -"?K'_?^S_^2*/MFM_]
M"?K'_?\ L_\ Y(KN**/91"YP_P!LUO\ Z$_6/^_]G_\ )%'VS6_^A/UC_O\
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M .2*/MFM_P#0GZQ_W_L__DBNXHH]E$+G#_;-;_Z$_6/^_P#9_P#R11]LUO\
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M*LFT_3HK=Y6E=>68DGD^F>U7:Q-D%%%% !1110 4444 %%%% !1110 4444
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MP*GW%:PGS"-"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y;QJ2S>'[8_<GU5
M0P]=D,TH_P#'HU/X4ZF>,O\ C]\+_P#85;_TCN:?7-5W&@HHHK(84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4WP42C>(+8?<@U5M@]-\
M,,I_\>D8_C3J9X-_X_?%'_857_TCMJUI;B9U5%%%=(@HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#E?&7_ !^^%_\ L*M_Z1W-/IGC+_C]\+_]A5O_ $CN:?7-5^(:
M.9UO6;GPSJ@O[UYKC1;E!'LCA#/;3C[H4*-S"3ISG#8Y /#;?4];M/LEA-!%
M>ZU>K)=O#),(8;2(%1L#JC%L%E4<$L=QR!@5K:[I/]M:<MIY_D[;B&?=LW?Z
MN17QC(Z[<9[9J+4](N;G4K;4].O([6]@C>$F: S1R1N5)!4,IR"JD$,._7-1
M=#*NF^*5U&\TVV%F\4EU'<F97?F"2!T1TZ?-\S'G(Z>_%_0=6_MO2([_ ,CR
M=\DB;-^[&R1DSG Z[<_C64GA.>R&G3:=J2I?6AN#)-=6_FK.9V#R$JK(02Z@
MC!XZ<UJ>'](.A:+#IQN6N3&\C>:R!2V]V?D#C/S8X_(=*';H!E6OC)+B[TBV
M>Q9);V6XAGQ)D6SQ,4P>!G<XP.E9M]XMO)5EDM?,MP4L98LLCJ8I;QHMV"F0
M6C )Y(&X8Y&XW+OP*ES<:Y-'J,D+ZBT+P%8Q_HC(V\E>>=S\GIZ<U9U#PA'>
M7#O#=""(P64"1B+.P6\YE'<=<[?;&>>E/W0+GAJ^N=0LKR2ZD\QX]1NX$.T#
M"),ZJ./0 "LM_&DD&GZCJ-U8006=M>26,+O> &:593&"<J%1.Y8L2,'@XYW-
M&TO^R;:XA\[S?.NY[G.W;CS)&?;U/3=C/?':L]O"P;1KBQ%ZZ3-?R:A!<)&,
MPR-,95^4DA@"<$=QGIGA:7 H6WCVVG@O$6.TN;Z!X8XX]/O1<13-,VR,"3:N
M/F!W97@<\U8U'Q7<Z+;(-6L;*SNYK@0P&34 MLXV[BQE905  ((*9S@#.<U9
MGT+4=1L9H]2U=)+CS8IK9K>U$4<#QL&5MI9F;+#YLM@C@!>267&@ZI=F"ZGU
MF+^TK6?S;:2.SVPQC:593&7+,&!.<OUP1C')H!GQ>-!J,%FUBL4MP=2:RD2U
MNTDA=A \@Q)L.Y#A>0%(/T(-E_'%I'IUE?-;N(9M/DO[@;OF@1 H*X/!8NVW
M&1T/I5UM#O;IM.EO]46>>SOC=G9;"-"/+>,(JY)4?/G+,QR#V( HVW@6SB_M
MV.:YED@U3<B(@V&U0LSE4.3_ !R.V<=P,<4_= =H'C*#6-5_LUVTXW#P&=/L
M&H+=J%! 97(5=K?,..0><'BI]1U[4X=>GTK3='CO'ALDO&DDN_*!#,ZA!\C?
M,=G'0'G)&!F[IEEK$$V_4]7BNU6,(J068A#'N[Y9B6X_AVCD\'C&/>Z?K,_C
MB]FTZ\%E"^EP1&:6T,J,WF3$[3N7#J"#U(^;D'BEI<"O=_$2P7[/]B?3\26:
M7A_M#4%M#M<$JJ AMS\'(X XYYK0L?%,FKZM:VVFV"26DUA!?M<33F,I'(SC
M;M"G+#9TR!UY&.60^%;C2&C/A[4DLP+2.TD2ZMS<*XC!".,.F' + ]0>..*T
MK31VMM;DU)[QYW>RAM#YB*&)1I&WDK@9/F= H''OP.P$.KZU>66L:=I=AI\=
MU/>Q32!I;@Q)&(]F=Q",>=_8'G'8Y%.V\5SZC!IJ:;IL<M_=Q22R0S7/EQPK
M&P1\N%8GYR ,+SR3C%:UQI?VC7[#5/.V_9()X?+VYW^88SG.>,>7Z<Y]JQ[7
MPG<Z9#8R:=J<<=[:BX0RS6QDCDCED\PJ4#J<@[<$-V/'/!H!5C\57]YK6C&&
M"*WL98KK[=%-+AXY(657'"'.TYQ@C=DYQ@9=H_Q L]5U*QMLV 2_+"W6#4%F
MG7"E@)H@!Y>5!Z%L'@U;A\(K;MIK)>>8;?[1]I,T6XW/GD-*>&&TEAQU !QB
MK.D:-JFF"UM7UI9M.M$,<,0M0LKJ!A!)(6(; [JJDD D]07H!LP&9H5-Q'''
M*1\RQN74?0D#/Y"E\&_\?OBC_L*K_P"D=M20"985%Q)')*!\S1H44_0$G'YF
ME\&_\?OBC_L*K_Z1VU52^(3.JHHHKI$%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW')('<GN3U)[DUO2BUJQ,MT445N(**** "BBB@ HHHH **** "BBB@ HHHH
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#=AT +C 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
M    T +C 8?____W]_=C6F.,A(SO[^_>YMX 4L4Q,3&]O;V<I:4Z0CK6ULY2
M2E+>UMZ<E)S.SLYS>WN4C)126E*]O<5*2DIS<VNMK:5K:VN$A(2MM:TZ.C$
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M7^_]2LM28(+KW%7__?DF$2  " -,SCR[Z,=?$C]?;FRA\?+GWQ'@+%[8O?X
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M2HNF^Z#?Z-[G)N#0ORGJU)8> $81_\%[144^L*%,Y.0@$F !+04 \E ." <
M4I=_<7$=H_$N_+ .:V)U2#81Q2$ )S ;>P5D 1  ]S O\K%:*8)!3G(/?10
MED>!=R$<)N B_,(T)2 !PX<0 X J E* "!$A_' B#Q)/3B)<OC0 $=4!R2>#
M2Y0J<T9H6(<07@(F1C*"!>$ 3-4/974 \  G<L)*"P !%1!(3G@7$#2%>'(L
M$B  $I  >F<0@)(!@[).)W40D+,9CV(?"" IE#)Z Z%P9_@6%J  _="!^T(
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MJ0,=)&(_'"JH#/^A)8,$0 '@HL6" )S9$)-R$A+*J/L02-+D0 \@ #HZ*_+
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M^[S0&[W2.[W46[W1.PX0^D6!%+,2=:!*9A_/_\59!4$;[6 ;#L"Y D(;CD0
M(( /-5F3/A(B[UN3^. T##*_B*0OLH2_N<=,_82_\2N!N(*_^" DM(J_B*0>
MK(&_>CHR ,PY!XB_]HO JJ+ ""R6ZH/  7PF"%R_LY$J^!NB^SN_DN._&BP@
M_C# \UO 0T+!Z?)<%TR+_SN_%, YZ4#!+;-[(6S!#%PL&0S -*+"[^O!,(7
M(;H J=(!2+ $!H ,R+ !!A#%!@#%4US%5GS%5(S%4IS%7+S%7AS%70S&7ZS%
M8ES&9'S&88S&8YS&;+S&;FS&;0S';ZS&<ES'9[S%+^$ AY@ ZK"Y#I"]%?%0
M]\  $F(!Y4)+!X!BTO]QEL?Q7"HG(=W"+#7T>&<&  6@&1-@BQ,P 6]D9@\
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MV9$ SY<!91(!_3 I_OJ2\\ !N W1TY#5]^';8C$/M_D9]  ?7F(B.!42][#
M./<V-P4 *&;(*%8FM+$EO7QK^-&MF;UW* #%#XT,5U 0V%V!UK4?-UT>/]2
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M&38PP!,,]Z* 24M!4G':#RWH (0.0OW( C-Q_%0!3PM242('VB$@6L<.*&"
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M9+X!_(B ?]?Q=-$FX #W*!P_9IEX  R@'!6_1QK]Z]U+)SN!V.9A(I,0_V#
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M"J4K3:MX##DS',$Y !"0!X6B$NO:J 'HB0DP/2$S 02H !.0 'DPG)TKJN)
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M;AP=!JA!G1QATF ?A6B <G#@];C7I;X)W:C1(.%&5XZ)VS0/OMTOOJ6]ADA
MEN@,)(56[@H >%B  K#3V-AIC4-+LC1"Y-R(A#*!"-CG[Z#J[;EIU%F ).B4
MB2@[EG@>"S"M(U0(PY H%9&R%[8A4EPZ_6-CD1B $G!7G^:+@D-7(^P=L$)5
MB^W3RT35'>[LL0,KD^/@VN UM-"_E> ->SB!P#EMQ] _?O"'(7)KY7F>>Y@
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M^'A F9X'Q)&FI/9H IB "* 'HO=HFCY?,J(,"=<9"U!%G<10M>GH!$#NET
M 3B!YG ;1<I,%Y[.E*VK "F'G"P-$>'QD4GKL!CJX?[I(^8.6#4;;F0="+0P
M>_B+E.V'CSE;UA)F 2@ ?)@ [9!NTU"1+(4<[ 3CG'9[\Q$1%7KWN0:OJ1\9
M6A:*73-"A1)=W2B!":"B,Q,K"O [T0/()CWTK6@?=0"^S5E[L)#QQO_I2I(
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M?A@'!? '3E3 5*B#PR +^7H$2*"/?@@ .VSIW8URB(8=!81R9TB !."#7R#
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M'BEHH%/>+L,.*PC&I%11?MP$0 ('ZS*4(AK] 2 !"A9@9P*W.H!4R;&(L^"
MB11U4+->@RRHMX0@X.Q2"R00[5IR1WN V'7JLH\DDQJX_^<R!2R(@#-D*1J
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1_O6W__WQGW_][Y__60L( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.gif
M1TE&.#=AT *. 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M4X]WR]QKSW?VWEL_?O?GBU\]^.2G7S[[Z(?__O7MR]^R^?;;OS[]\;>_O_L
M_%_^_/<]_HE/?P4$( +Q5S\",K!_Z!-@ R.8P %2\($'="#\,GC!#6Y/@P;\
M8 =#&, *3E!])H0@"C$HPA5ZL(0LA.$+%SA#$"K0AA9T(0EIN$,<GG!^[MN;
M?/]49B">R*8D!5C0_0 GN+WM[7M/9,7BF@B *%9Q>5/DFQ.7=T6\93%E7=1:
M%+^X12ABD8E:#&,8R:C&,:(1C%9T8]^H&,<SSC&-=?3B&\LH1CM>$8Y<E.,?
M^;C&/;;1CW0,)"+QJ$@]WA&09G3D( \IR41&4HJ&S",F'TE(05JRCY5DY"79
MJ$E2-G*3DRQE)D]IRE&NTI6<I"0J/UG(6*K2EJQ\I7Q:MC4D@45Z\_%&RLQG
MOEVR+'U+9%G*=AF^9(*/B,C\W_6@V4QI:I&9V7/F-+&9P&)><S[53. VP9E-
M:RZ3G-V,V3FC*<YOLM.;ZPPG/*E9SG;&LY[SY"8QU4G_SW0JLY_[_*<^M>E.
M>?)SH.8$*$'OZ<]G(M2>"DWH0_.)SH ZM*(+C2A$)WI0C$K4HQL%*47?&3->
MRH=K7TDB.$S0,I9R,7$)<-P0JSC'P=W1I3,5)DW!>46<7E&G.D6C3YU84Y[N
M;:@[#>I-YY/3H@J5J3]UZE);1M2=/I6J2;5I3Z%:5:5N%:M U>I1N9I5HQ*.
MK&$U*U+3>M6F6G6J;O7J6,$JU:_&5:QGI>M;[1K5O<[UKFI%:UW_VE>YYA6P
M;2TL7M<ZV,,J-K!Z-2QC_>K8KBY6L)2=K&29NL65/G%P066>\\0"3&,^,YM:
MU)JY]FG18[(,GRE;YVN[&5MH_\Z6F+4U[?IP*TS;+I&WLOWM_7(+U=T.M[>Z
M_1YP?6O<ZA$W9K!%;G&5>]S@-K=[TH4N;;-[V^HRE[K.Y:YPPVM=\&*WO-%%
M[W;5N]SDIO>[[W7O>N$[7_FV=[KQQ6]]]7M?[?:WN^2E[W+[AC(Q M%\O1R+
MR7;)2\_"]'O4'5SB>IM& @O3I2L%@+F>J#<+9YAO+-UPX#R,X1!WL<.*^W"&
M19SB%)=8PR?6:8=?S&(4SQB<)N:PC"^,8QCKF,0]KO&.59SC$;LXR#$&,HA]
M;.0;+UG(2EYQDH_\Y"D[6<H_IC*6F\SC*F?YRD5N,9B9+.8N;[G,1":SC<T<
MYC6G&?_*6F[SD&EL93:K><Y(_K*=X3QF/N_YI]@U@;GN1V$'#^ZDODQIODQ*
M4R*&5:G>L*@PL]E;,,XTO--$60*%B-U,]\U\G-8>$5.F:5 ?U].;/K462XU5
M3*_ZTZWN]*M3[6I2P_K2LK8UK7/M#5;C6M2H-G6M>WWK*P[;U\;F-;)#?4Y=
M"UO9Q6;VJ(F]:V#/^MG6=G:LLTUM;#>[V]O^]K)5K>U?BSO:Y :WN:<][F.C
MV]W5/G>\V?WN[J',B2AC*8-M+3@#)YBT#3@T5)EGW'U"$8P.'G@"[?U2*5+/
M<=IS*?,<7B^(?WCB.HUIXB+>\(Q;7.)8?/C&+Q[RBH\<Y%[_%/G@. YABFM\
MY21/N<EACG*7?[SC*E]>S&U^<IS/7.<U]WC/6RYTFOO\Y4 _^LV)GG.&,_WG
M3L=XTUDN=:A3O>1(CSK6EU[UK%]=YE[?>=&3_O2P!WWJ8D?[V:U.8":1K\.+
MH[CUGJAQ"J#4*TE\*8,9K ^6WK'25.7>I&&<.%A;&IQC)?CW#I]&EBI>:XP'
MH^,5'OG$4Y[3C8?P^BI_UL>GD9F67R+G)R]ZS$M>\XLW?>@WK_K.7[[!JT\]
M[%U?^MF3GO6V1SWD6W][V8.>]KC_?>]WGWO/CU[WGT<\\'VO_.$G/_/&YSWR
MCQ_]XK]>^-.7?O6QO_WF9S_;3/K?_\3GT_<&RT-7V0K+@H,)<YJ:X-['=63A
M4(Q/"KNWMC7%_&OQWVA&!SC__G=>CQ: HA9;_7=_@&=_^,5_"@A=#,AX^Y>
M$.A= (B !MB $7B!$_A_![B $JA_%-B!#OB!!/B (,B!&!B"*8B"&RB %>B!
M&GB"+BB"&3B %FB#,(B#(QB#)4B"-_B".YA6S -4)05:4-522Y8!$5 !Z> M
MI+5H_U-!U,9%!,9O>3-[8V5:TU-%DR=&FA943-2%7.A484A=U :&<R2&9RAA
M:6B&7\B&7.B&9-B&E/:&6]AK<FA595B'<QB'?*B'= A%=FA4:CB(>RB(?8B'
M?XB&?HB(@/_8B%Z8B(4HB7G(B(KHB)8XB8]XB9&XB9J8B94(AYPXAIX8BG?X
MB:*(BJ=HBH3(BH<H1I563UP%,PW&5"D0 0B  .F0:'@7<!C&52MG?PJH4\RS
M4H,F'QTF:A4V>/\$8F#46A4&?]"(<-*84<ZX-],H.-684-?84-/4C=D(CM:X
M4L\XCML(4>+(C>2(C>98CNIXCO.4CNBXCMX8C>XXC_#(3_(8C_08COW8CNSX
MCO?(C_G8C/\HD &)CP.ICP>ID G)CRWU1#"EC6\5=_)A 4N0B_"PBPJV:(*7
M?\48:7[#:(I'C% %1L(%2G,$:O!79&\8B6,E8B\YAC'94S4%DV?_)9,W29,Y
M:9,TA9,NN9/$5I-')90MR60S.90]690_R9-!V91*^92#%Y5(:92GIY-0>918
M.95:Z9-<>95>*7A=R91?292$8Y5FF91C>999"99D*99NR99EN91R"9=IB99T
MJ99QJ9=WV99].9=2V4PU4XP&EDW6TP%0( Y0( &XF(M,Z(3JMR1]9'";5U)[
M-W" MT]M=XPIYW?N%XL":'(7!IH%*$1$!7?R(XR?&5ODHYJCR9JAJ7&O.7BE
M*9J>!9NU*9NW29NU99NHV9J6=IJDV9NZ^9NQ*9RX29S(R9NNN9NI&9RKR9S0
M.9O/:9K169V^.9S-:9RYN9S869S:.9W._PF<UDF=Y)F=R;F=X5F>XWF<UWF>
MX)F>XLF=RCE(*[=3&J>,%08 3S !N?B?"+ $V. #O-@5>7<^*'F!!W>$\K%:
M33)Y0=5;NP=_L":A6L0]#0=AW--WI,93V52%$_J+'WJ6(>JABT>BJR:B)UI@
M*6JBD(>BI*:B+\JB,>JB@$.CO2:C-\H]-0HX(XJC[V>C(-JB/KJB/)JC0@JC
M2%JD,WJD0<JD.UJB4#JD/0IK32JE5AJE1)JE5+JD7*JD3_JE0*JC71JF$0:F
M9(JF23JF:^JD:<JF4ZJF<<JBLCA37WAO""8! (H &I"+2U .!<H5)O-AH59
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MZ+"[5'[45;/8TY@:D)%]B@ 6 " UT39>\QX)@ [RD"ZXP2"HT3;OP3;R )D
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M1!, )$I,,6')08P8(;""Z/'C0XD/'8+T*%+DPXX0&20(X/(ES)@R9]*L2;,
M P,,"@2(Q],;@WD/# 0 8. ! P8  N!D\* E*WP!H"%]&B!!TG?T8!9H(#(!
M0["LP'ES.!8 V+1HUZIMR_:MV[APV7I#6[9C@KMDP>&=*_>L7+!^!_\+#NQ7
MKPE] #J2M;N7,&3#;OM*CFQ9;4?&9>'>A;SV\F!P)NJ"W=RVL^'/E0V+)@W
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M"DUZ:1DL,2!?E>'(*%X]"E6KH<F+@(FG64GLT!1<L4U*68HX:AZ?N:=[PJ
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MX14C7.:/5ID ,(]K@^ZC6?ZFLR;MGI"O35$L4565N%#*^Y#CL%(OA'K_X_K
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M0433H@LZ*URZ0%6ZIF^ZHL=#+>,N2++#/LP#3@/  S1 3K1$3H Y3S/W533
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M4)V2K3ZF&[/H2Y1J089%B[DKR,\JY^D[N)IU:]>O8<=^W0\: P,&+EP0.+"
MP0 ,Y*$S<-!  0 ,!!:8MYH5 U8!"AC84'P@\M4).5:$"-%$3@"LM@- Z3 \
M^)/?&R+U7AX .(<<46H7/S^!=_CMZ9-$F=UA_9[Q&?H,I0'G<Z_ _/:SZ3Z(
M]N,NI_>TZ\[ !?$SSR:(LCL/0_8X,J\]\K[;$#_O ,S.IOTJQ K##^T+#S\
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M^SI=2$?R+@3 6DDI"FM9<"'*R::HQEVI6XO .;8B<EFR_U9'R-35=UW*Q,N
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MFBNZ!\J;&HWF.J$5%$!H:\\3HHF "O]@@+X,*2 "S@DM[MCO600%V+IF*#3
M.=<$ !K?(AF*DXK\3E[RW6YH7!DICR$X?0>FB 7^^K1HJND)&:!2B-,DF#/M
MA;"'J63*_J@B:SE09TZ#0 ;BU6$+_,4"YP6D;O,C/6Q]BYU]6^.SQCM9T1 -
MOADBT+1$>+LX1@IM-K*1OHZ5MN[&:< %QF+QQ(<ZMLDG<$?-+D2<DUPUK]EP
MZ+A 36QGH P+R+?1:JU<T\>U?[TT2SB<\G1#YCHHP8VZ1@SDZX!)47^JR+QY
MCG!B-^+;^#WI=US:,YXPX#2GLNEB\K" 8#$@CQ1RMCNM=$@V;WC:=T:HD$?R
MY6]W:B2CLBS_G1(65X=I&L<I*E(>$GB"/.0EZAT/-K]+4).Q(V#L%AL[OT[=
MRXZQAX%KK8C,>F1%TPJ+F/SER4M<LA-U<VRQ<G&7M>01E"N1HB32V:^@O,6J
MN]FGPU8'+:0K$M3&2+W:OFG-GZKLLTD+6MZ&L<2X;#;XP:^C$)*Y%I#F(MTC
M_0W5[G+OO7V,J:/]9C]%IVA@V)3:%,'KQUD^&,P=YB&WN(6P]\I0;5:DV"/M
MZ5@15TD"80.'S)U6@0Q:('"GOIN0=]EA]5BXX=_%3Y5+-LL_!;!J2U^1?5%'
MR(39S1L92('!$E#C"'0( \Z4)E]6?"9JYG<P@^'9-+$WS<?N);!6_X* >' F
M,VLUD60)P*_3L(=C-Z9+*U%!W7:QA4<=_6Y]Q;-OA85,:2(_E[1SXA-(MTPQ
ME/$3Y/>R><;-W$BEC^CBG3?40E/*\"\BG/0')Q:^IXAZU'L,8EK\-NM":J<G
MWD_5D;8?(=_94_>*YW7!U6&Z@&_2WXZH]H#F:>CEY8W:E02 &>+2EN9J :?F
MM3 2V''X5JSVO4P "L43LQ2SYKO\"1"=/KTJ>HJD;^Z=[XJ53G??^-1[U JW
MI9]>@@L%BP )4  <3R!FE5(@ZYHMQ-!DF@KPKCK FV:.+YQJA72NQ_)G8\ A
ME*1)'AI,M:).=D0$4OX,ISS$D)R,2!0KM?\\8T\D8GK28R3Z15."C]&PJ*7@
M*WB,9>!HZ?7@:*>4[[2(S\,NS9*&S(J<8@/F 8Q*KP@W*B$4R<L(K"8>"23>
MZ*#ZQKE833O(!N-,!.3:*GE@+-<<CI(B;^2>#VOV9ZEX9\IH:>H0YD5@2)U,
MY) RK3#**9HF0!Y8@0+-KNP0 (%J2R7JQ8,6;J?XC96T3&ZJ[0F_ZP)!"E]F
MR9_:$'5D:U 2P (DX+_6KDJ>8"XJ2TTBP *4CQ*EB; $HP+ 3@,J8.P0  K4
MI>M0[.NB:>L^R'P X,0 C-,FZS2XI23^!UU.#G=6Z<>TXLG^3O0,2:B$;(F*
MYWW2IFA RV'(1>+_VFI(O&7JA@9KVC##-J\-O<]NQ.LX5,,(O1&CB$6*C(05
MQ ].G.26B(+U% OV+(D&G;&G* ;/4.0TXN-\YC%18BOUX@]@ZB>J',WXB@=2
MJFB'. ]\3D("+@@"#41!G,*OJD3:P$$"=F:#0"R_SF0"QN!:RN<%-6MOS*KY
MN(BDT(\&:T*$/"2SD HKUK%$?LIX "!G"F/$'G(#!' OH*#FQ".4-"![ */L
M-/&;6)$OVB,#,(AG/A$/MR\"C"EK"D067VAC;L1]C@].:(E[CBJT/M!-EJK.
MMBV7/B_#^"[.-DO,V(76HI)]O*6F]H;,=F>'=@<E2.BEXBWBT&5VGH>-_W"J
MX+YQ+P\'"8>F;B NM*2N9":,%W>JI$KK\V9,K%3J1B1OVQXSF,2&6\),79@,
M^"H3T(SO6SX)M$[D":*-KO3*%9D2)][0A3ZCZUH,P-YP)Z' J01#@BP  K7L
MR'I"XR**A]QILD1(.]KFI8JF'P$*CW)0PV[3IL3#_PBP[)I& C:@(A%@#%:&
M%7I- EBBZWZRUZI$L#2 3<@C X9M[=!$[/C".VO&LQ( @^!P2>AE(I),PM0G
MPD#*=M*FBK!L[ZB%8?BFIWS)-C7BR2"O%XV&A-XSX&JO;OI(OJKE!.=,70K-
M87SQE3Y#+_FR0D4%.P Q\ZB+'IFH0[W%E^;C7/\2"L_@K,Y JT'&$$77DAVO
MTJUB#(I*\K9XB,C4,'4H#E&\0QXT8*JT<SO!IV;\XR028$PD"QPJ4OM.T3"6
M( 6\0147\!0YR!]/]$7WA\[,\$$KS2K[IJA:-*N6BK-F2RP7X@U%;#7W8@PL
MX+]ZID+2C23D@1+#B2:?P"\$:^M.BP(^C>S41!1K3@(@B.>N)?^T[?Q B.7$
M2:LP$(80A3^(RX<DC"J'1T9.9$^""*8R##*<9'D:L>D<BFYD4%^J\OLTQ&K,
MP^<NYC;7T%O.49^&T$)==526"[H2R>%V!.3*)GG^9:?L2T')TE9)J]WX[N=P
MQXJ8;S*G%"<<+\=N[;3_JLCOP,N+=HW)/N/N"B/_6 A[),OJGL 3V:0B9#'%
M=G)-8K$O!&-,M@^S(LHD%7.I-&YW[*LW=\1H%O$R-Q2^TB>;F,M[(O*$#! I
M*Y$OQ.ET/$0B]T*R3B(#G.J%_.Z^9#*_H, "EJ"9$,"8&JA.8>9@L!"UJ SB
MR.NF2@X^'8^\[L=?7&M=I+$_)\F>6(]]]&8Q?4A;+B1@5VF^AD:URBRMD+46
MK5):KO'CIF;B&* ;7W5H72,A&/2S<JCDUH?I(,P'65*?ZB=WF&5/R"_/]D11
M\L>>V"LK(8;:&A662,W#O.='T^^*4B H4:P"1)'[@*VRHHF__B5/_[5*](X5
M_]+S:?(OA7!/?FQ4IM)C!&$MD>32X_BHU4H'%^'34>3R-!ZH+_X+-J6IJ2PR
M:H(KXCYM)S.  FHDTY8  Z!1^0#@;*?J+UXS[30-LD8) $!3$SDHWK"48^S$
ME[1K_;C'/_@EBL8//R3PP8 04S-/B6R-L31D^,QL&5?-]KYL1;N*B6;J$4\R
MQT3K00B2X(B0:(DVC5AF-[56;#@4$--';EKTR,AC!4%5#:GR:G.PJ+@WQG;D
M'MN-)"[O;#!B:> +R8J2-('B9.KJ=)_4:: @9\SU[<@B!<PU_U+77.RP 5M7
MRI:F61W4D:;,$:/U;CZO9RD,9#)0:[YRX?;I>OY/T_^8+0]/K #%]>-^;L98
MX7O$+1+ID//P(P,B*-1.P@(Z@!7(E,62B16BJ?N>!Z@T-F;1LRN9BQ#3;;P:
M35T=S <E*C>?1YS4"F203,(2DUSL*\E6*61,-MZ ZFVRH]9<-GG?ZS%'SWK)
M&#I&)WW"UJ4\L@3Q:!B/*&-,]$LSI3-GIM]>1W@$A7ZJ4G=]=BHEKL)NC=LP
M=2,B0&*?( 7*1#^\X5OQ4.>P3<0F@!6.U"9MY"4-8\5$3 _CX^XTL4HB*]+:
MA']RJ-M0\A&GQSRH:_ARC-8Z=+-6-LR\(P/(KF"'32\L0!Y::(-H:*AP"GZE
MS"16SFX5:2$H8'_5;CRY+P7_\D^ 3<I 1-(<_?$*X_6]-F]<;L=+NO12CH<M
MK4V1CC%.RJ_Y8BC7C(BSHG($F^Q+W;%P\QA1A[7>DF^,R_AZWXQ]FU$C<(=<
M^@UV*,/FK$7T<&)KI69(Y(E]G^Z2>.A<"A,,B6ME!6B5^4Z?;3@F!\,5<<9/
MVXX!F4T#0@TP\@]JJ'63C(DEY-9I" ,G-X):"<.IH@:['/A%_XR)455KTX4*
M85<WK>OST/ ,HX(5"!AM4S<! (._KNTH-< Z=3<*F\5%/HG(+OB*'M@S*-!:
M<6YB0P:;! WJ^+E7YT5O "F>+N+R"(5$J<5$F&S(I":=RK=\VA-YLE&4Y^>?
M\&U$__K0EWDIG=P7\Y2,E-)WBC*$0N>Y0A-B1+]R0$H+)6<&SRCO?/4X/YID
M!%G*FX$FFWXG4[=$_5CJ3599M>23=19F$LEN":!@A:#)?W=4E&3K--'$D0L#
M A"#4>J4%359<,[V#HV23!P-:QQ/CY)(; W5(R.%_;C*]HP$W&IHBV*Q%24H
M,O;#A B#^_[EB0AE^"KS \]R!B'3.QA9Q*[G(?GP$5NKC>7FIR"JC1;+=(0+
MN)D5?5/OG#\4/T59#"];SLA;46<)?=HHO>$R=^0L2<*M8Z1HPV G(.45E%LU
ML(<6>[]8W[36X[ICCG:0^<JJ/MM+7<4RR[!K1LE"-Q>3@_^7;K60XIF#3/=J
MIP[_S]EF^6GP#WM2:"'D8=F<#0.0,5)PN0+4! *Z.SI'Q 1D4=E$3,:UN"2W
MD;Q BFV&>;QL&N8")\X64S!C#(A%DZ*UC7O^HS7W B)#%1YQT':BFFD+LWTA
M \0PV2>?YL:8]8YZ::#CI%X4&KS^+K^!"O="JL !$_#R)Q 5*7_3?'$?V,B1
MCH+K)I\7SS<A$4\(G.YHAUCAJ(H9 K 1G#4T:C4B?2!@8]+[P8Q$1P+OIV?;
MS4BHEJ%$=3_C&YW#U,\TDWWKAT&'!-8,M;68;X)UHI=S<K ,,(3YM?K(:3:O
ML@[O,)JZ]6\ H .<+9P, R/I!F+_%]"N$D#(X(3>1(N1L&@M!W<D4V1.<FP\
M,JL9N\JWI,^3(V#7OT-'($(6L^=KVKAI[\0\VK%JN*MJP44!JW7F)L!S.W7
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MFR@)FQ#*^&9CL3Y?9E8=M:OCRI_):I9HD$&" +Q[^_X-/+CPX<,+_&/ H#<
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MQU_9A''_LH09!G*F6" Y%F-7F(9-AW7-1US95Q:@\6U^-Q2\R!4DB%[Q,8G
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M#&$!MB64!&$!E]":<J&'/!D2'3B4A/%5206 1<) <S$A H&%('02Q<9Y0IB
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M&=.:1FX<<H:T=H3L\2=C5YTU]W35E6M8MV"G1<:1H7^Z)I@1K:)=;-=I%W6
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M-+$,JJXPIV21/C<I4@M#^<;#L+JKT!SK20!,P^U4_U2' R\>"@!H%;I3"V"
M@0<2V""U!"YXYP'3^J'U@0=Z*V#76E4KH %@"P@ '&(-N TU=*:S"*G1#A(0
M@2>,I,XJM?*R2%#"P-6VS9L0!4LGLK 2-P$),-C1)"%/RN]%)7TL5[$L#SI0
M+D+#JVNKN_3:#-*IP'.,NL\*;M3?RQ($K:9RQ6/7I(X6%F_:,2C.@+22Y$UH
M I@2Z!B!_RRXSIN130)YIJ!&BF ,"4S^%"V:?Q(*JS5;K/DQAN'Z"L$22Z0)
MJT_9RLJ$.45+--2J]M2IT4WK)"_<R#0CL^K/<FHJ2IT@[#>K\OA5;"[PJJQ0
MM+(/5 K4@00*;$&JB!X/W?_(>#+2PH,/SHDIOY2JBBX'2TTN5<)Q!:('Q!-'
MG(%4335@GM0 ^,: 6U$K8(%X F"@ !,8Z&T?QE%+P%30XS% V02"C:Z!]0QL
M%"&%)!CM._$@H_TIR#HU*T:("6Y;//!J;YWE&+&T8 (EDU<9"E<O@<<_DDVF
M**GW6%;W=]PMKI"B3A\,:D0_T2+8+'T@5'!<P9Q:C[*LM@6?)9.@^!=$#.E=
MTD0,5#8)@AM=PD >$<DG?R<A&4EV5Q%Z$2DK27$;=<3$/=JU[S)<HI/=?K<M
M$XGG0'2BBOC@YI.WJ>]0@T+3=;SB%0ZJSRO=$U\'S2.T&"F-('NJG95L1T&*
MZ"/_)673%)THTT _I2\H<VJ06:ID/319!#QBX=GK&M9#',ZPANQ;U*+Z\KX1
MH<54A>-B GI0"MF$$8P/(%P\Y/$ 9:&F5+PRP&D88 #4&.!T#,@<."X0G="-
M#AP/\ 9JB@6MZ<3M8E7Q!KWD9YZ%\:0JA:%25G 6IP,2A&#6J19I8F0D\HA,
M>1J 7@0B  $-/.$C U0(-NQU21A:LE%&/"&;VH8E@+4/2VO1%"(55D/NJ2V5
M/HF;PQ8FCY),  KJL25DO)$QY)G,:"WA47^0IYV+440>.[K6DC)PGP3(0P+7
M8EXQ+2:67-+207FYX!+U-!>H5"4P[=N;=;9TR0M*D'@X_W/((MN7)YK5$C(_
M_(OOT"/(F01M2I6I$]W:MI4+4O)O<LJ*."-)'? $+Y*2>N==&LD>E> ,B0L]
MB]'<,[W '52<U2'H%KE(..Y4A (G30TX&, -=*3&=&V45:G@&  #;(Z, <A5
M:@RPT]2QHECQN$!R2H6"X!2 'DD%CCKHT3$(N*.I2Y4J<+Z1U*4R-3CNR*HZ
MM!J<JWZUJ@48*UF9Z@ZO)G4?*9  %*!7P'<A  +[V,<83E< ;O!H"=S8!U/3
MNM6O!C:P705.5I-:5<..M:]F#:M6Q^K4 BSVKP5(:UF;"EC,%@ "$\A(4B%+
MV,AR(P(:X(96]Z&DA&BDF@B0P/]DS>J.9KKD)&,8[2>55-H"A+6Q52UK8R=;
M6<,6]K+ 62Q6@?-8QPK6LG>-K&>5:E9Z6#:XP8$L8BG+U.ABMK'7%>YA<ZO5
MWP8VK-8MK&6':U[H'E>]W 4.<WT;V,5.-SCR_6I:0?O5[)K5NTNE[W>'*]CG
MRFIP+"T< ![0  0W8!]<-/" 4_/&?]Q4CK):J0D:D!K0J=$T[SA-/_Y8J@N
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M0U1N#(0H+=G#2-;SZ?6?#RA(2]] N &1YA3140$YJ3P)%$B@G=$ \C# "GG
M"\E0D </%V0P[H$^]9]O?.)!GW?I!_\4\'9[&O:MCWW'ZX5XTW<@Z&N?>NU7
MG_H\-$P#@5C/Q+L_GMNZ8*#F#W_<USZ:X;<2+6D9O&T1&O 3#\J /__[/#&9
MENM#/49"/_(3'*HCG 4  M.YHPMP-]SXC=/IC5*YE6&##G"0(Z.2(WE #7"0
MN]]8@#32-P/8![O3MX([F?/YCA1XI@GP.X,HG_,Q&ZMP"U:PD0QP&$/QAA3
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M8,;0L!N)<A.;"0R!82BCT9DZD0R+X N'T!(A$HG]@0( V0C9\08P_]27@=B
ME * D8D7UN(=-ZF9!;**.M$7)404HL&7 M09"\*+ZZF=QD"HH2% AV29Q<B:
M0?F,$!+'A'1*);2_$ (7<'&,D%R+@%D;WP%*G/BGDT28?M2+T?#*J<&D>>K'
MJN"+\E@BT-";"0++J3C*SNA(\4$H:?S&UGB[>%"W4G"P @/,J@LD!^'$H1B)
M(=D8:-S!O"P3 ,B XCL)'Z&)#) '"UBM)S@2"(@ AD@ RT/(?ADA'<P J$J
M5S&4@5BY[1E"/;0B2N%$)=P7HZ2=\U$)7"P2=R+'[^&05K030%F@*5E+C*Q+
M.]%$222A@B!-"P"@WG.)"1@#08R)FI!'B/_!B-_[O9,PF2EYBI_Q$D>"CP:9
M"2(ZE+#((EN\HOF9BO*02]MAP@YZBASLD+[9GJ\9C+8$D;XAE=ND)!4*2G*T
M(G2"E!'YESQAE.0TDQRB"O@(0P3%%($H'\*H)_NXFPXR0,R@S)^D#!W*E*CQ
MBDD,#PTM#<-$S-U C5N1G)A"3!AMC6/90Y"@2[[K#WGXB)V\(<&#FI'QNZ'
M@ J0LHTX/HA 'I9$@"6 @"?(C_R0'K94O&F*G=$SR?11#XJR/L\X"+Y@(D$R
ME)E9T&&$2J;D%[QHI+/9EZ4$J<30"2U1&Z10I&_ZGI@ PY#L"JK1* HP@8Z9
MPI@Q$J3Y2>)AA8[_Z<Z(\!$U&8Q!X9<:E<JG:50%] Z^05/ZVSXE%-&FM+^F
M5-3$X,/LE,E\^@E%091/W52)V=&X:*0Q%12[=+Q9HLI+_8L\K!K9 U206LIN
M>4J[>2#V825E#!6@#-2NJ:4M1:A^W*?T.1BC^4L8M;I20($4C5%IO3M$$@NX
M2)'OK$4-I9Z=X*4G?"8(H P+B( CVQ_21++DJ<[V$0V9D(<DT0#PY)($U!:\
MD-!\JLK,D \H80LQ,;Q=?!0=I!H[!!P>O,5:'(U&')0N'1%6A<],X10++<[@
M'"BH^!@(T%?U:2!</,%WJ28B"1[<,5ACQ"1,@<G?7"?:L</><5A)34.[_QF1
M-&RD^AR4KR$1"*%,1347XLF4.K%#.DW ]22AW.D;DE*3+A4A?Y',\!S0\>1#
M8208"Q65@AT+\B' 5D18;X&2/>00WXS)KA4(9D5, +@ 2(B$,8K6:?W&8[$H
MK_0*/ZP DXD+NL&7[I./DM"("K@/(-$(OBV@)6$FG$R>BM&)#+  MS"(EN (
M94(B5>VEI+3*B]%(@"&+)I0;MNU+.EPD,,$:+PW4IV1+$\(7RH3#=>2,!0*\
M5O3<K6$1(GS2/(S,<3%3^TDMA3B^#%63"]7$AI6*OL'523E9"=E+G770!B75
MNNF)\ZB/^<24<9R:B"G>"ET;HAS#833>8-V6./_%50L2FH_,"<,8%[!<"JQ
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M)" > 7!K,]G:*09R2E0!,( !]-J/ "2@F+QA1X[!G>,&QD/%A"W6[GKR,1-
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M N $.J'J,1#C"5X&!,'7:&$#'$<_), W]%4  (#_X\V56_'&/!A  3B V"0
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MIFHA+996K8;E*RZ('OKS)9$\\HC1I\@+%5I"I8TVH7D4,W/+!(+H89_)(#&
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MT$,LD5;&@P=1YW,&1JG0QHND9$$P<(N@;4P" !\^@TOPP>]8S #F 1_V80$
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MHS9J*\2?4O9L.39F:W:#2LZ(VB(\TD5J*D30FF5G\>+'6$C4PNILH448M:@
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MV8?>"(:8^)9X*)>2&(R[*(YJV(A>>(=S^9>R^)>$29AJ>)ATN8M#>(:6&)>
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M2G2Z,(AD;;K,<^ZW4_IG&\^8%6L#L.MWO6OA:UBU6^WC'&+B;OI@RRH=9PW
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MWVA,!X7*S@,]B2]6K'3@R5@X;+[&"84:(P.\9+#N+%Z$$'(-UVI*YN$8)OZ
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MDS1EYG[ PXU"]I><UA6G*:VC4Z3XIYG*[&4E &@7XV!HF 1<X $U5)P!:,@
M  2@  ^X #_T$9@EU= O">#& QI0 "%>8&HH*M#:-B:9L^4(0^CA77&<9S9B
M*0QHPGDBVHXFH,LDR(HZTA?BZC8\S_QN.ZKS$,Z.-CWV1(1%=%S-&*^(N^:
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MG[<14:=<\+:%4@*N8C2C09EUB8)#R!=!<#B*< 9G0 ,]67F2N6:7@?=FJL2
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M+'N-]\HW9?2@<Y/<ZV@G3 %U3C)A':M_1\-6T"3@ 1NH*P,$[!D&>", \7A
M#0-0_X ' & #5@% /"J,X0QK>,,6;@B%.<SA?FSXP@"@@%5(#.(.FQC%'(['
MARO,X@N_.,4-,7&',2SC#+-XQ!7^L(UO_.$=GQC$0FXQC77,8P[_V"I+3O*1
M;QQCJ_BX(46F\I$OW&0-SQC$67ZRE[OLY12_N,I#+O.'MVQE+Q<Y $:>,(_1
M[.(:'WG)9'8SDL.,9Q3'8P$/_J^?Z_J > 0@ 1<(C0$./.@'L,+! >C'!6K8
M#P:@8!_T,("EOV& ;[CC&_O@M 'V\>E/>QK4!0@UJ#6=:5"#VM*A+K4!7&T
M==!CU:IF-:MKG6E+NR/5EH;UJ3L-;$Q[&M.KOO2F8=UK6_];NM*YQO6N7VV
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M/>TU3WO;QYX?'. &[1G@^M'#/O>?__WE26\"M/\YP(/F1VC0,0]!L_5@K @
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M<(P%X'G0^0 -D%:'UIS829^AT4P-< ')-R9B& \F )%LUI^LD0 &N8GZ&0#
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MB\8 ^0 $F6@FZ-  [G"."K,!@*>HDZH:!O  #K.C9<(!%%FH:MB>8\(./<
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M!^,9B!? >]I,\O -9<P:#H ")W@P\X /W4"^J,$*)\#&[^"U<+P:*AL ^L
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M]KJ@;T9QU!UZ?05IGR"R;,PT2C\Z;N*30&4-*7R@20!?F>@Y05"8H WI@B!
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MRTVLA4;@9"! AZS6-YCT@#WQLI\0_>=3 @J$@08'&K;C*"X+THW_!^"-HN
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M7_SC)W_YS7]^]*=?_>MG?_O=_W[XQU_^\Z=__>U_?_SG7__[YW___?]_  Q
M 1Q  BQ  SQ !$Q !5Q !FQ !WQ "(Q "9Q $0JL0 N\0 S,0 W<0 [<OX
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 03, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 3,033,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 418.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 03, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 3,033,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">418.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">418.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 3,033,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236836_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236836_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236836_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236836_exfilingfees.htm">dp236836_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236836_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236836_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236836_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236836_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236836_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236836_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236836_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236836_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-25-014164-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-014164-xbrl.zip
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>9F5E<RYH=&U02P4&      $  0!'    B L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp236836_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">3033</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">3033000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">418.86</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">3033000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">418.86</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">418.86</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">3033000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
